LOS ANGELES, Feb 28, 2008 (AFP) - US officials Thursday said 40,000 people may have been infected with HIV and hepatitis in a major health scare after a Las Vegas clinic was found to have re-used syringes and medicine vials.
Authorities in southern Nevada said they were notifying some 40,000 patients who received anesthesia injections at the clinic's endoscopy center between March 2004 and January 11, 2008 about potential exposure to hepatitis and HIV.
They recommended in a statement that the patients "contact their primary care physicians or health care providers to get tested for hepatitis C as well as hepatitis B and HIV."
The move comes after several acute cases of hepatitis C showed up in the area. Six people have been diagnosed with the disease since January, which is three times higher than the yearly average for the Las Vegas region.
The three first cases came to light in January, and three other patients were subsequently found to have been infected with hepatitis C.
Five of the infected people all received anesthesia injections on the same day in the Endoscopy Center of Southern Nevada in the sprawling city of Las Vegas.
No cases of HIV or hepatitis B infections related to the clinic's practices have been detected yet, authorities said.
After an investigation, "the health district determined that unsafe injection practices related to the administration of anesthesia medication might have exposed patients to the blood of other patients," it said.
"The joint investigation identified the re-use of syringes (not needles) and the use of single dose vials of anesthesia medication on multiple patients as the potential sources of contamination."
Action has since been taken by the clinic to end such practices.
"It appears the injection practices that can lead to the transmission of hepatitis C and other bloodborne infections have been occurring at this clinic for several years," said chief health officer Lawrence Sands.
"We are recommending all patients during this timeframe to get tested because we cannot determine which patients may have been exposed."
Hepatitis C can result in severe liver damage, but the symptoms may not show up for several years so even if patients are feeling well they should be tested, he warned.
The health authorities added however that the risk to the general population was low as hepatitis cannot be spread by casual contact.
The clinic said in a statement that it has taken corrective measures.
"On behalf of the Endoscopy Center of Southern Nevada, we want to express our deep concern about this incident to the many patients who have put their trust in us over the years," the statement read.
"As always, our patients remain our primary responsibility and we have already corrected the situation," officials at the facility said.
"We have already taken steps to ensure that it will never happen again ... We want to be sure that every patient who may have been exposed is informed and tested."
The Endoscopy Center of Southern Nevada said it was working with "nationally renowned experts who have extensive epidemiological experience" on how best to proceed, as it tried to tamp down public fears.
"We wish to emphasize that the actual risk of anyone being affected by this is extremely low, but as a precaution, anyone who has undergone procedures at the Endoscopy Center who required anesthesia should be tested."
080228
AF080245
Copyright ©AFP 2008. All Rights Reserved. AFP articles contained on the AEGiS web site may not be reproduced, distributed, transmitted, displayed, published or broadcast without AFP's prior written permission. You may make one copy of each article for your personal, non-commercial use only; more copies would require AFP's prior written permission obtained from the owners of any trademarks or copyrighted materials whose marks and materials are included in AFP photos or materials. Therefore you will be solely responsible for obtaining any and all necessary releases from whatever individuals and/or entities necessary for any uses of AFP stories, photos or graphics. http://www.afp.com/
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.